Patents by Inventor Soon-Mi Won

Soon-Mi Won has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOSITIONS AND METHODS FOR TREATING REPERFUSION INJURY OR HEMORRHAGE AFTER RECANALIZATION THERAPY
    Publication number: 20230390231
    Abstract: The present invention relates to pharmaceutical compositions and methods for treating ischemic stroke in humans, using a tetrafluorobenzyl derivative of formula (I) or a pharmaceutically acceptable salt thereof conjointly with a thrombolytic drug, endovascular thrombectomy, or both (e.g., endovascular thrombectomy and a thrombolytic drug). Administration of a tetrafluorobenzyl derivative of formula (I) or its pharmaceutically acceptable salt can reduce reperfusion injury and other adverse events in patients conjointly receiving a thrombolytic drug, endovascular thrombectomy, or endovascular thrombectomy with a thrombolytic drug.
    Type: Application
    Filed: August 21, 2023
    Publication date: December 7, 2023
    Inventors: Byoung Joo GWAG, Chun San An, Jing Yu Jin, Sung Ig Cho, Fangmeng Zhu, Xinliang Xu, Weiqiang Zhan, Fuxin Liu, Soon-Mi Won
  • Compositions and methods for treating reperfusion injury or hemorrhage after recanalization therapy
    Patent number: 11826329
    Abstract: The present invention relates to pharmaceutical compositions and methods for treating ischemic stroke in humans, using a tetrafluorobenzyl derivative of formula (I) or a pharmaceutically acceptable salt thereof conjointly with a thrombolytic drug, endovascular thrombectomy, or both (e.g., endovascular thrombectomy and a thrombolytic drug). Administration of a tetrafluorobenzyl derivative of formula (I) or its pharmaceutically acceptable salt can reduce reperfusion injury and other adverse events in patients conjointly receiving a thrombolytic drug, endovascular thrombectomy, or endovascular thrombectomy with a thrombolytic drug.
    Type: Grant
    Filed: March 10, 2021
    Date of Patent: November 28, 2023
    Assignee: GNT Pharma Co., Ltd.
    Inventors: Byoung Joo Gwag, Chun San An, Jing Yu Jin, Sung Ig Cho, Fangmeng Zhu, Xinliang Xu, Weiqiang Zhan, Fuxin Liu, Soon-Mi Won
  • COSMETIC COMPOSITION INCLUDING 5-BENZYLAMINOSALICYLIC ACID DERIVATIVE, AND TOPICAL USE THEREOF
    Publication number: 20220249343
    Abstract: The present invention relates to a composition comprising: a 5-benzyl aminosalicylic acid compound in chemical formula I or cosmetically acceptable salts thereof; and a cosmetically acceptable excipient suitable for local administration. The composition comprising the 5-benzyl aminosalicylic acid compound in chemical formula I or cosmetically acceptable salts thereof can be used for reducing or alleviating human skin aging by means of antioxidant, anti-inflammatory and whitening actions on the skin.
    Type: Application
    Filed: July 8, 2020
    Publication date: August 11, 2022
    Applicant: GNT PHARMA CO., LTD.
    Inventors: Jin Hee SHIN, Byoung Joo GWAG, Soon Mi WON
  • COMPOSITIONS AND METHODS FOR TREATING REPERFUSION INJURY OR HEMORRHAGE AFTER RECANALIZATION THERAPY
    Publication number: 20210283080
    Abstract: The present invention relates to pharmaceutical compositions and methods for treating ischemic stroke in humans, using a tetrafluorobenzyl derivative of formula (I) or a pharmaceutically acceptable salt thereof conjointly with a thrombolytic drug, endovascular thrombectomy, or both (e.g., endovascular thrombectomy and a thrombolytic drug). Administration of a tetrafluorobenzyl derivative of formula (I) or its pharmaceutically acceptable salt can reduce reperfusion injury and other adverse events in patients conjointly receiving a thrombolytic drug, endovascular thrombectomy, or endovascular thrombectomy with a thrombolytic drug.
    Type: Application
    Filed: March 10, 2021
    Publication date: September 16, 2021
    Inventors: Byoung Joo Gwag, Chun San An, Jing Yu Jin, Sung Ig Cho, Fangmeng Zhu, Xinliang Xu, Weiqiang Zhan, Fuxin Liu, Soon-Mi Won